FDA cannot keep track of medical devices and their manufacturers
This article was originally published in Clinica
Executive Summary
The US General Accounting Office (GAO) has identified "several weaknesses" in the FDA's regulation of medical device tracking which it says threatens the agency's ability to adequately protect the public.